Вы искали: peptide (Английский - Мальтийский)

b-type natriuretic peptide (bnp)
natriuretic peptide tat-tip b (bnp - b-type natriuretic peptide)

type 1 diabetes (c-peptide negative)
dijabete tip 1 (c-peptajd negattiv)

diabetes mellitus type 1, c-peptide negative.
dijabete mellitus ta’ tip 1, c-peptide negattiv.

a gp100 peptide vaccine is an experimental control.
a it-tilqima b’gp100 peptide hi kontroll sperimentali.

lixisenatide is a peptide and is not metabolised by cytochrome p450.
lixisenatide hu peptide u mhux metabolizzat minn cytochrome p450.

further metabolism involves peptide hydrolysis and n-acetylation.
metaboliżmu ulterjuri jinvolvi idrolisi tal-peptide u n-acetylation.

the peptide itself has a lower affinity for these receptors.
il- peptajd innifsu għandu inqas tendenza li jintrabat ma 'dawn ir- reċetturi.

this prevents incorporation of amino acid residues into elongating peptide chains.
dan jimpeddixxi l-inkorporazzjoni ta’ residwi ta’ aċidi amminiċi fi ktajjen ta’ peptide mtawla.

as a peptide, enfuvirtide can cause cutaneous amyloidosis at the injection site.
bħala peptide, enfuvirtide jista’ jikkawża amilojdosi fil-ġilda fis-sit tal-injezzjoni.

laronidase is a protein and is expected to be metabolically degraded through peptide hydrolysis.
laronidase hu proteina u hu mistenni li jiddegrada metabolikament permezz ta’ l-idrolisi tal-peptidi.

agalsidase beta is a protein and is expected to be metabolically degraded through peptide hydrolysis.
agalsidase beta hi proteina u hi mistennija li tkun degradata metabolikament permezz ta’ l-idrolisi tal-peptidi.

the metabolites are small peptide fragments formed by enzymatic hydrolysis of ganirelix at restricted sites.
il-metaboliti huma biċċiet żgħar ta' peptidi ffurmati wara l-idrolosi enżimatika fuq il-ganirelix f’ siti ristretti.

type 1 diabetes (insulin-dependent diabetes mellitus, c-peptide negative)
dijabete tip 1 (dijabete mellitus dipendenti fuq l-insulina, c-peptajd negattiv)

linaclotide is a 14-amino acid synthetic peptide structurally related to the endogenous guanylin peptide family.
linaclotide huwa peptide sintetiku ta’ 14-amino acid strutturalment relatat mal-familja endoġena tal-peptide guanylin.

aliskiren is an orally active, non-peptide, potent and selective direct inhibitor of human renin.
aliskiren huwa inibitur dirett tar-renin tal-bniedem, attiv b’mod orali, selettiv u potenti, mhux peptajd.

aliskiren aliskiren is an orally active, non-peptide, potent and selective direct inhibitor of human renin.
aliskiren aliskiren huwa inibitur dirett tar- renin tal- bniedem, attiv b’ mod orali, selettiv u potenti, mhux peptajd.

dapagliflozin has not been studied in combination with glucagon-like peptide 1 (glp-1) analogues.
dapagliflozin għadu ma ġiex studjat f’kombinazzjoni ma’ analogi ta’ glucagon-like peptide 1 (glp-1).

in addition, vorapaxar inhibits thrombin receptor agonist peptide (trap)-induced platelet aggregation without affecting coagulation parameters.
barra dan, vorapaxar jinibixxi t-tagħqid tal-plejtlits ikkaġunat mill-peptajd agonist tar-riċettur ta’ thrombin (trap - thrombin receptor agonist peptide) mingħajr ma jaffettwa l-parametri ta’ koagulazzjoni.

b-type natriuretic peptide (bnp) levels were reduced by 25% in the aliskiren arm compared to placebo.
il- livelli ta ’ peptajd natrijuretiku tat- tip- b (bnp) kienu mnaqqsa b’ 25% fil- fergħa ta ’ aliskiren meta mqabbla mal- plaċebo.

not known: blood parathyroid hormone increased, blood insulin decreased, insulin c-peptide decreased, weight decreased.
mhux magħruf: żieda tal-ormon tal-paratirojde fid-demm, tnaqqis ta’ l-insulina fid-demma, tnaqqis ta’ c-peptide ta’ l-insulina, tnaqqis fil-piż.